{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T16:41:11Z","timestamp":1789749671244,"version":"4.0.1"},"reference-count":94,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Veterinary Clinics of North America: Equine Practice"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.cveq.2016.11.003","type":"journal-article","created":{"date-parts":[[2017,2,9]],"date-time":"2017-02-09T14:00:36Z","timestamp":1486648836000},"page":"127-139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Therapeutics for Equine Endocrine Disorders"],"prefix":"10.1016","volume":"33","author":[{"given":"Andy E.","family":"Durham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.cveq.2016.11.003_bib1","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.2460\/javma.2004.224.1123","article-title":"Evaluation of suspected pituitary pars intermedia dysfunction in horses with laminitis","volume":"224","author":"Donaldson","year":"2004","journal-title":"J\u00a0Am Vet Med Assoc"},{"issue":"3","key":"10.1016\/j.cveq.2016.11.003_bib2","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.domaniend.2011.05.004","article-title":"The prevalence of endocrinopathic laminitis among horses presented for laminitis at a first-opinion\/referral equine hospital","volume":"41","author":"Karikoski","year":"2011","journal-title":"Domest Anim Endocrinol"},{"issue":"4","key":"10.1016\/j.cveq.2016.11.003_bib3","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/evj.12445","article-title":"Treatment of equine metabolic syndrome: a clinical case series","volume":"48","author":"Morgan","year":"2016","journal-title":"Equine Vet J"},{"issue":"3","key":"10.1016\/j.cveq.2016.11.003_bib4","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1210\/endo-123-3-1598","article-title":"Equine Cushing's disease: differential regulation of beta-endorphin processing in tumors of the intermediate pituitary","volume":"123","author":"Millington","year":"1988","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.cveq.2016.11.003_bib5","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1210\/endo-110-4-1430","article-title":"Equine Cushing's disease: plasma immunoreactive proopiolipomelanocortin peptide and cortisol levels basally and in response to diagnostic tests","volume":"110","author":"Orth","year":"1982","journal-title":"Endocrinology"},{"issue":"10","key":"10.1016\/j.cveq.2016.11.003_bib6","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/BF03345330","article-title":"Melanotrope cells as a model to understand the (patho)physiological regulation of hormone secretion","volume":"28","author":"Vazquez-Martinez","year":"2005","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"5","key":"10.1016\/j.cveq.2016.11.003_bib7","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1111\/j.1939-1676.2011.00784.x","article-title":"Computed tomographic findings in the pituitary gland and brain of horses with pituitary pars intermedia dysfunction","volume":"25","author":"Pease","year":"2011","journal-title":"J\u00a0Vet Intern Med"},{"issue":"1","key":"10.1016\/j.cveq.2016.11.003_bib8","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11102-005-5085-2","article-title":"Pharmacologic resistance in prolactinoma patients","volume":"8","author":"Molitch","year":"2005","journal-title":"Pituitary"},{"key":"10.1016\/j.cveq.2016.11.003_bib9","series-title":"Freedom of information summary. Prascend tablets, pergolide mesylate, for the control of clinical signs associated with pituitary pars intermedia dysfunction (equine Cushing's disease) in horses","first-page":"141","author":"Andrews","year":"2011"},{"issue":"4","key":"10.1016\/j.cveq.2016.11.003_bib10","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/eve.12160","article-title":"Pituitary pars intermedia dysfunction: diagnosis and treatment","volume":"26","author":"Durham","year":"2014","journal-title":"Equine Vet Educ"},{"issue":"4","key":"10.1016\/j.cveq.2016.11.003_bib11","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1111\/j.1939-1676.2012.00932.x","article-title":"Diagnostic frequency, response to therapy, and long-term prognosis among horses and ponies with pituitary par intermedia dysfunction, 1993-2004","volume":"26","author":"Rohrbach","year":"2012","journal-title":"J\u00a0Vet Intern Med"},{"issue":"7","key":"10.1016\/j.cveq.2016.11.003_bib12","doi-asserted-by":"crossref","first-page":"679","DOI":"10.2746\/042516402776250333","article-title":"Plasma adrenocorticotropin (ACTH) concentrations and clinical response in horses treated for equine Cushing's disease with cyproheptadine or pergolide","volume":"34","author":"Perkins","year":"2002","journal-title":"Equine Vet J"},{"issue":"6","key":"10.1016\/j.cveq.2016.11.003_bib13","first-page":"742","article-title":"Treatment with pergolide or cyproheptadine of pituitary pars intermedia dysfunction (equine Cushing's disease)","volume":"16","author":"Donaldson","year":"2002","journal-title":"J\u00a0Vet Intern Med"},{"key":"10.1016\/j.cveq.2016.11.003_bib14","doi-asserted-by":"crossref","first-page":"598","DOI":"10.21836\/PEM20100416","article-title":"Equine Cushing\u2019s syndrome. The effects of long-term therapy with pergolide","volume":"26","author":"Pongratz","year":"2010","journal-title":"Pferdeheilkunde"},{"issue":"3","key":"10.1016\/j.cveq.2016.11.003_bib15","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1159\/000126764","article-title":"Decreased expression of the two D2 dopamine receptor isoforms in bromocriptine-resistant prolactinomas","volume":"60","author":"Caccavelli","year":"1994","journal-title":"Neuroendocrinology"},{"issue":"1","key":"10.1016\/j.cveq.2016.11.003_bib16","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1354\/vp.45-1-26","article-title":"Correlation of pituitary histomorphometry with adrenocorticotrophic hormone response to domperidone administration in the diagnosis of equine pituitary pars intermedia dysfunction","volume":"45","author":"Miller","year":"2008","journal-title":"Vet Pathol"},{"issue":"2\u20133","key":"10.1016\/j.cveq.2016.11.003_bib17","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jcpa.2015.11.006","article-title":"Age-related qualitative histological and quantitative stereological changes in the equine pituitary","volume":"154","author":"Leitenbacher","year":"2016","journal-title":"J\u00a0Comp Pathol"},{"issue":"6","key":"10.1016\/j.cveq.2016.11.003_bib18","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1210\/jcem-50-6-1026","article-title":"A\u00a0broad spectrum of prolactin suppression by bromocriptine in hyperprolactinemic women: a study of serum prolactin and bromocriptine levels after acute and chronic administration of bromocriptine","volume":"50","author":"Thorner","year":"1980","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.cveq.2016.11.003_bib19","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1210\/jcem-69-3-500","article-title":"Resistance to bromocriptine in prolactinomas","volume":"69","author":"Pellegrini","year":"1989","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.cveq.2016.11.003_bib20","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1046\/j.1365-2826.1996.04902.x","article-title":"Alteration of G alpha subunits mRNA levels in bromocriptine resistant prolactinomas","volume":"8","author":"Caccavelli","year":"1996","journal-title":"J\u00a0Neuroendocrinol"},{"issue":"1","key":"10.1016\/j.cveq.2016.11.003_bib21","first-page":"E1","article-title":"Single-dose oral pharmacokinetics of pergolide mesylate in healthy adult mares","volume":"11","author":"Gehring","year":"2010","journal-title":"Vet Ther"},{"issue":"2","key":"10.1016\/j.cveq.2016.11.003_bib22","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2460\/ajvr.76.2.155","article-title":"Pharmacokinetics of pergolide after intravenous administration to horses","volume":"76","author":"Rendle","year":"2015","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.cveq.2016.11.003_bib23","series-title":"Pharmacokinetics of pergolide in normal mares. Master of Science Thesis","author":"Wright","year":"2009"},{"key":"10.1016\/j.cveq.2016.11.003_bib24","first-page":"154","article-title":"Low-dose pergolide mesylate treatment for equine hypophyseal adenomas (Cushing's syndrome)","volume":"41","author":"Peters","year":"1995","journal-title":"Proc. AAEP"},{"key":"10.1016\/j.cveq.2016.11.003_bib25","unstructured":"Grotepa\u00df D, Failing K, Fey K. Influence of once versus twice daily application of pergolide on ACTH levels in equines with PPID. 2nd European Equine Endocrinology Symposium. Windsor, UK: May 14\u201316, 2014."},{"issue":"3","key":"10.1016\/j.cveq.2016.11.003_bib26","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1210\/jcem.82.3.3822","article-title":"Prolactinomas resistant to standard dopamine agonists respond to chronic cabergoline treatment","volume":"82","author":"Colao","year":"1997","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.cveq.2016.11.003_bib27","first-page":"375","article-title":"Long-term pergolide treatment of hyperprolactinemic patients previously unsuccessfully treated with dopaminergic drugs","volume":"27","author":"Berezin","year":"1991","journal-title":"Isr J Med Sci"},{"issue":"5","key":"10.1016\/j.cveq.2016.11.003_bib28","first-page":"411","article-title":"Efficacy of quinagolide in resistance to dopamine agonists: results of a multicenter study. Club de l'Hypophyse","volume":"61","author":"Rohmer","year":"2000","journal-title":"Ann Endocrinol (Paris)"},{"issue":"3","key":"10.1016\/j.cveq.2016.11.003_bib29","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.2042-3292.1992.tb01591.x","article-title":"Effective long-term treatment of a suspected pituitary adenoma with bromocryptine mesylate in a pony","volume":"4","author":"Beck","year":"1992","journal-title":"Equine Vet Educ"},{"key":"10.1016\/j.cveq.2016.11.003_bib30","article-title":"Long-term treatment of insulin-insensitive mares with cabergoline: effects on prolactin and melanocyte stimulating hormone responses to sulpiride and on indices of insulin sensitivity","volume":"34","author":"Valencia","year":"2014","journal-title":"J\u00a0Equine Vet Sci"},{"issue":"4","key":"10.1016\/j.cveq.2016.11.003_bib31","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1172\/JCI110324","article-title":"Direct effects of thyrotropin-releasing hormone, cyproheptadine, and dopamine on adrenocorticotropin secretion from human corticotroph adenoma cells in\u00a0vitro","volume":"68","author":"Ishibashi","year":"1981","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.cveq.2016.11.003_bib32","first-page":"22","article-title":"The Michigan Cushing's project","volume":"47","author":"Schott","year":"2001","journal-title":"Proc. AAEP"},{"issue":"4","key":"10.1016\/j.cveq.2016.11.003_bib33","doi-asserted-by":"crossref","first-page":"414","DOI":"10.2746\/042516403776014271","article-title":"Efficacy of trilostane for the treatment of equine Cushing's syndrome","volume":"35","author":"McGowan","year":"2003","journal-title":"Equine Vet J"},{"issue":"3","key":"10.1016\/j.cveq.2016.11.003_bib34","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2746\/0425164044877288","article-title":"Serum insulin concentrations in horses with equine Cushing's syndrome: response to a cortisol inhibitor and prognostic value","volume":"36","author":"McGowan","year":"2004","journal-title":"Equine Vet J"},{"key":"10.1016\/j.cveq.2016.11.003_bib35","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0739-7240(94)00006-M","article-title":"Laboratory diagnosis of equine pituitary pars intermedia adenoma","volume":"12","author":"Van der Kolk","year":"1994","journal-title":"Domest Anim Endocrinol"},{"issue":"6","key":"10.1016\/j.cveq.2016.11.003_bib36","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1111\/j.1939-1676.2011.00810.x","article-title":"Comparison of cortisol and ACTH responses after administration of thyrotropin releasing hormone in normal horses and those with pituitary pars intermedia dysfunction","volume":"25","author":"Beech","year":"2011","journal-title":"J\u00a0Vet Intern Med"},{"issue":"4","key":"10.1016\/j.cveq.2016.11.003_bib37","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.domaniend.2005.07.005","article-title":"Alpha-melanocyte stimulating hormone release in response to thyrotropin releasing hormone in healthy horses, horses with pituitary pars intermedia dysfunction and equine pars intermedia explants","volume":"30","author":"McFarlane","year":"2006","journal-title":"Domest Anim Endocrinol"},{"issue":"2","key":"10.1016\/j.cveq.2016.11.003_bib38","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0749-0739(02)00006-8","article-title":"The equine metabolic syndrome peripheral Cushing's syndrome","volume":"18","author":"Johnson","year":"2002","journal-title":"Vet Clin North Am Equine Pract"},{"issue":"3","key":"10.1016\/j.cveq.2016.11.003_bib39","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.tvjl.2007.07.003","article-title":"Induction of laminitis by prolonged hyperinsulinaemia in clinically normal ponies","volume":"174","author":"Asplin","year":"2007","journal-title":"Vet J"},{"issue":"2","key":"10.1016\/j.cveq.2016.11.003_bib40","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2746\/042516409X475779","article-title":"Equine laminitis: induced by 48\u00a0h hyperinsulinaemia in Standardbred horses","volume":"42","author":"de Laat","year":"2010","journal-title":"Equine Vet J"},{"issue":"4","key":"10.1016\/j.cveq.2016.11.003_bib41","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jevs.2013.09.006","article-title":"Assessment of Insulin and Glucose Dynamics by Using an Oral Sugar Test in Horses","volume":"34","author":"Schuver","year":"2014","journal-title":"J\u00a0Equine Vet Sci"},{"issue":"21","key":"10.1016\/j.cveq.2016.11.003_bib42","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1136\/vr.100911","article-title":"Effects of body weight reduction on blood adipokines and subcutaneous adipose tissue adipokine mRNA expression profiles in obese ponies","volume":"171","author":"Ungru","year":"2012","journal-title":"Vet Rec"},{"issue":"1","key":"10.1016\/j.cveq.2016.11.003_bib43","doi-asserted-by":"crossref","first-page":"76","DOI":"10.2460\/ajvr.69.1.76","article-title":"Effects of long-term oral administration of levothyroxine sodium on glucose dynamics in healthy adult horses","volume":"69","author":"Frank","year":"2008","journal-title":"Am J Vet Res"},{"issue":"1","key":"10.1016\/j.cveq.2016.11.003_bib44","doi-asserted-by":"crossref","first-page":"68","DOI":"10.2460\/ajvr.69.1.68","article-title":"Effects of long-term oral administration of levothyroxine sodium on serum thyroid hormone concentrations, clinicopathologic variables, and echocardiographic measurements in healthy adult horses","volume":"69","author":"Frank","year":"2008","journal-title":"Am J Vet Res"},{"issue":"6","key":"10.1016\/j.cveq.2016.11.003_bib45","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.2460\/ajvr.2005.66.1025","article-title":"Effects of oral administration of levothyroxine sodium on serum concentrations of thyroid gland hormones and responses to injections of thyrotropin-releasing hormone in healthy adult mares","volume":"66","author":"Sommardahl","year":"2005","journal-title":"Am J Vet Res"},{"issue":"2","key":"10.1016\/j.cveq.2016.11.003_bib46","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.tvjl.2012.09.020","article-title":"Weight loss resistance: a further consideration for the nutritional management of obese Equidae","volume":"194","author":"Argo","year":"2012","journal-title":"Vet J"},{"issue":"1","key":"10.1016\/j.cveq.2016.11.003_bib47","doi-asserted-by":"crossref","first-page":"140","DOI":"10.2337\/dc14-2441","article-title":"Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of diabetes","volume":"38","author":"Inzucchi","year":"2015","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.cveq.2016.11.003_bib48","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2746\/042516408X273648","article-title":"The effect of metformin on measurements of insulin sensitivity and beta cell response in 18 horses and ponies with insulin resistance","volume":"40","author":"Durham","year":"2008","journal-title":"Equine Vet J"},{"issue":"10","key":"10.1016\/j.cveq.2016.11.003_bib49","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.2460\/ajvr.71.10.1201","article-title":"Pharmacokinetics of metformin after enteral administration in insulin-resistant ponies","volume":"71","author":"Tinworth","year":"2010","journal-title":"Am J Vet Res"},{"issue":"1","key":"10.1016\/j.cveq.2016.11.003_bib50","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.tvjl.2011.01.015","article-title":"The effect of oral metformin on insulin sensitivity in insulin-resistant ponies","volume":"191","author":"Tinworth","year":"2012","journal-title":"Vet J"},{"issue":"5","key":"10.1016\/j.cveq.2016.11.003_bib51","doi-asserted-by":"crossref","first-page":"665","DOI":"10.2460\/ajvr.70.5.665","article-title":"Pharmacokinetics and bioavailability of metformin in horses","volume":"70","author":"Hustace","year":"2009","journal-title":"Am J Vet Res"},{"issue":"1","key":"10.1016\/j.cveq.2016.11.003_bib52","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.tvjl.2011.08.003","article-title":"Metformin in equine metabolic syndrome: an enigma or a dead duck?","volume":"191","author":"Durham","year":"2012","journal-title":"Vet J"},{"issue":"3","key":"10.1016\/j.cveq.2016.11.003_bib53","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1001\/jama.287.3.360","article-title":"Oral antihyperglycemic therapy for Type 2 diabetes","volume":"287","author":"Inzucchi","year":"2002","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.cveq.2016.11.003_bib54","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/BF00562061","article-title":"Pharmacokinetics of metformin after intravenous and oral administration to man","volume":"16","author":"Pentikainen","year":"1979","journal-title":"Eur J Clin Pharmacol"},{"issue":"8","key":"10.1016\/j.cveq.2016.11.003_bib55","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1007\/s00125-008-1053-5","article-title":"Metformin and the intestine","volume":"51","author":"Bailey","year":"2008","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.cveq.2016.11.003_bib56","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3109\/00498259409043220","article-title":"Accumulation of metformin by tissues of the normal and diabetic mouse","volume":"24","author":"Wilcock","year":"1994","journal-title":"Xenobiotica"},{"issue":"3","key":"10.1016\/j.cveq.2016.11.003_bib57","first-page":"301","article-title":"Metformin-induced regulation of the intestinal D-glucose transporters","volume":"61","author":"Sakar","year":"2010","journal-title":"J\u00a0Physiol Pharmacol"},{"issue":"6","key":"10.1016\/j.cveq.2016.11.003_bib58","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/evj.12068","article-title":"Effects of metformin hydrochloride on blood glucose and insulin responses to oral dextrose in horses","volume":"45","author":"Rendle","year":"2013","journal-title":"Equine Vet J"},{"key":"10.1016\/j.cveq.2016.11.003_bib59","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1146\/annurev.med.52.1.239","article-title":"New oral therapies for type 2 diabetes mellitus: the glitazones or insulin sensitizers","volume":"52","author":"Mudaliar","year":"2001","journal-title":"Annu Rev Med"},{"issue":"3","key":"10.1016\/j.cveq.2016.11.003_bib60","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1365-2885.2010.01217.x","article-title":"Pharmacokinetics of pioglitazone after multiple oral dose administration in horses","volume":"34","author":"Wearn","year":"2011","journal-title":"J\u00a0Vet Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.cveq.2016.11.003_bib61","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1939-1676.2011.0681.x","article-title":"Effects of the insulin-sensitizing drug pioglitazone and lipopolysaccharide administration on insulin sensitivity in horses","volume":"25","author":"Suagee","year":"2011","journal-title":"J\u00a0Vet Intern Med"},{"issue":"1\u20132","key":"10.1016\/j.cveq.2016.11.003_bib62","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.vetimm.2011.10.007","article-title":"Effects of the insulin sensitizing drug, pioglitazone, and lipopolysaccharide administration on markers of systemic inflammation and clinical parameters in horses","volume":"145","author":"Wearn","year":"2012","journal-title":"Vet Immunol Immunopathol"},{"issue":"9","key":"10.1016\/j.cveq.2016.11.003_bib63","doi-asserted-by":"crossref","first-page":"924","DOI":"10.2746\/042516409X452152","article-title":"Type 2 diabetes mellitus with pancreatic \u03b2 cell dysfunction in 3 horses confirmed with minimal model analysis","volume":"41","author":"Durham","year":"2009","journal-title":"Equine Vet J"},{"issue":"4","key":"10.1016\/j.cveq.2016.11.003_bib64","first-page":"623","article-title":"Adenomas of the pars intermedia associated with hyperglycemia and glycosuria in two horses","volume":"56","author":"Loeb","year":"1966","journal-title":"Cornell Vet"},{"issue":"5","key":"10.1016\/j.cveq.2016.11.003_bib65","first-page":"506","article-title":"Insulin-dependent diabetes mellitus associated with presumed autoimmune polyendocrine syndrome in a mare","volume":"52","author":"Giri","year":"2011","journal-title":"Can Vet J"},{"issue":"9","key":"10.1016\/j.cveq.2016.11.003_bib66","first-page":"1168","article-title":"Diabetes mellitus secondary to chronic pancreatitis in a pony","volume":"153","author":"Jeffrey","year":"1968","journal-title":"J\u00a0Am Vet Med Assoc"},{"issue":"4","key":"10.1016\/j.cveq.2016.11.003_bib67","doi-asserted-by":"crossref","first-page":"584","DOI":"10.2460\/javma.2005.226.584","article-title":"Diabetes mellitus in a domesticated Spanish mustang","volume":"226","author":"Johnson","year":"2005","journal-title":"J\u00a0Am Vet Med Assoc"},{"issue":"1","key":"10.1016\/j.cveq.2016.11.003_bib68","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1177\/1040638714560606","article-title":"Equine pancreatic disease: a review and characterization of the lesions of four cases (2005-2014)","volume":"27","author":"Newman","year":"2015","journal-title":"J\u00a0Vet Diagn Invest"},{"issue":"1","key":"10.1016\/j.cveq.2016.11.003_bib69","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.2042-3306.1974.tb03919.x","article-title":"Diabetes mellitus in the horse: a case report and review of the literature","volume":"6","author":"Baker","year":"1974","journal-title":"Equine Vet J"},{"issue":"20","key":"10.1016\/j.cveq.2016.11.003_bib70","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1136\/vr.c5125","article-title":"Use of desmopressin eye drops in the treatment of equine congenital central diabetes insipidus","volume":"167","author":"Kranenburg","year":"2010","journal-title":"Vet Rec"},{"issue":"3","key":"10.1016\/j.cveq.2016.11.003_bib71","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.2042-3306.1983.tb01796.x","article-title":"Idiopathic diabetes insipidus in a Welsh pony","volume":"15","author":"Breukink","year":"1983","journal-title":"Equine Vet J"},{"issue":"1","key":"10.1016\/j.cveq.2016.11.003_bib72","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.cveq.2005.12.010","article-title":"Polydipsia and polyuria in a weanling colt caused by nephrogenic diabetes insipidus","volume":"22","author":"Brashier","year":"2006","journal-title":"Vet Clin North Am Equine Pract"},{"issue":"4","key":"10.1016\/j.cveq.2016.11.003_bib73","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1080\/00480169.2012.669723","article-title":"Nephrogenic diabetes insipidus in a 14-year-old gelding","volume":"60","author":"Morgan","year":"2012","journal-title":"N\u00a0Z Vet J"},{"issue":"2","key":"10.1016\/j.cveq.2016.11.003_bib74","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1939-1676.1993.tb03172.x","article-title":"Nephrogenic diabetes insipidus in sibling colts","volume":"7","author":"Schott","year":"1993","journal-title":"J\u00a0Vet Intern Med"},{"issue":"2","key":"10.1016\/j.cveq.2016.11.003_bib75","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.beem.2016.02.007","article-title":"Diabetes insipidus: differential diagnosis and management","volume":"30","author":"Robertson","year":"2016","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"11\u201312","key":"10.1016\/j.cveq.2016.11.003_bib76","first-page":"1047","article-title":"Desmopressin administration in children with central diabetes insipidus: a retrospective review","volume":"26","author":"Ooi","year":"2013","journal-title":"J\u00a0Pediatr Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.cveq.2016.11.003_bib77","doi-asserted-by":"crossref","first-page":"3840","DOI":"10.1093\/ndt\/gfq317","article-title":"Carbamazepine can induce kidney water absorption by increasing aquaporin 2 expression","volume":"25","author":"de Braganca","year":"2010","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1016\/j.cveq.2016.11.003_bib78","doi-asserted-by":"crossref","first-page":"208","DOI":"10.2746\/042516400776563617","article-title":"Headshaking in horses: possible aetiopathogenesis suggested by the results of diagnostic tests and several treatment regimes used in 20 cases","volume":"32","author":"Newton","year":"2000","journal-title":"Equine Vet J"},{"issue":"3","key":"10.1016\/j.cveq.2016.11.003_bib79","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.jpeds.2015.06.002","article-title":"Thiazide Diuretics in the Management of Young Children with Central Diabetes Insipidus","volume":"167","author":"Al Nofal","year":"2015","journal-title":"J\u00a0Pediatr"},{"issue":"12","key":"10.1016\/j.cveq.2016.11.003_bib80","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/j.1748-5827.1998.tb03714.x","article-title":"Successful long-term treatment of congenital nephrogenic diabetes insipidus in a dog","volume":"39","author":"Takemura","year":"1998","journal-title":"J\u00a0small Anim Pract"},{"issue":"2","key":"10.1016\/j.cveq.2016.11.003_bib81","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0034-5288(95)90039-X","article-title":"Prophylactic efficacy of phenytoin, acetazolamide and hydrochlorothiazide in horses with hyperkalaemic periodic paralysis","volume":"59","author":"Beech","year":"1995","journal-title":"Res Vet Sci"},{"issue":"4","key":"10.1016\/j.cveq.2016.11.003_bib82","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1476-5381.1977.tb07539.x","article-title":"The effect of diuretics on the faecal excretion of water and electrolytes in horses","volume":"60","author":"Alexander","year":"1977","journal-title":"Br J Pharmacol"},{"issue":"3","key":"10.1016\/j.cveq.2016.11.003_bib83","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.2042-3292.2011.00377.x","article-title":"Antidiuretic response of a horse affected with pituitarypars intermedia dysfunction to desmopressin acetate","volume":"25","author":"Moses","year":"2013","journal-title":"Equine Vet Educ"},{"issue":"1","key":"10.1016\/j.cveq.2016.11.003_bib84","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.cveq.2011.01.002","article-title":"Water homeostasis and diabetes insipidus in horses","volume":"27","author":"Schott","year":"2011","journal-title":"Vet Clin North Am Equine Pract"},{"issue":"1","key":"10.1016\/j.cveq.2016.11.003_bib85","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.cveq.2010.12.002","article-title":"Disorders of the equine thyroid gland","volume":"27","author":"Breuhaus","year":"2011","journal-title":"Vet Clin North Am Equine Pract"},{"issue":"6","key":"10.1016\/j.cveq.2016.11.003_bib86","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1939-1676.1998.tb02153.x","article-title":"Hyperthyroidism associated with a thyroid adenocarcinoma in a 21-year-old gelding","volume":"12","author":"Ramirez","year":"1998","journal-title":"J\u00a0Vet Intern Med"},{"issue":"7","key":"10.1016\/j.cveq.2016.11.003_bib87","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.2460\/javma.2000.217.1051","article-title":"Hemithyroidectomy in a horse with confirmed hyperthyroidism","volume":"217","author":"Alberts","year":"2000","journal-title":"J\u00a0Am Vet Med Assoc"},{"issue":"5","key":"10.1016\/j.cveq.2016.11.003_bib88","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1111\/j.1939-1676.2008.0169.x","article-title":"Propylthiouracil for treatment of hyperthyroidism in a horse","volume":"22","author":"Tan","year":"2008","journal-title":"J\u00a0Vet Intern Med"},{"issue":"1","key":"10.1016\/j.cveq.2016.11.003_bib89","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1378\/chest.08-1149","article-title":"Critical illness-related corticosteroid insufficiency","volume":"135","author":"Marik","year":"2009","journal-title":"Chest"},{"issue":"10","key":"10.1016\/j.cveq.2016.11.003_bib90","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.2460\/javma.1998.212.10.1594","article-title":"Adrenal insufficiency in a neonatal foal","volume":"212","author":"Couetil","year":"1998","journal-title":"J\u00a0Am Vet Med Assoc"},{"issue":"4","key":"10.1016\/j.cveq.2016.11.003_bib91","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/j.1939-1676.2009.0323.x","article-title":"Hypothalamic-pituitary-adrenal axis dysfunction in hospitalized neonatal foals","volume":"23","author":"Hart","year":"2009","journal-title":"J\u00a0Vet Intern Med"},{"issue":"1","key":"10.1016\/j.cveq.2016.11.003_bib92","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.cveq.2010.12.005","article-title":"Adrenocortical insufficiency in horses and foals","volume":"27","author":"Hart","year":"2011","journal-title":"Vet Clin North Am Equine Pract"},{"issue":"1","key":"10.1016\/j.cveq.2016.11.003_bib93","first-page":"107","article-title":"Controversies surrounding critical illness-related corticosteroid insufficiency in animals","volume":"25","author":"Creedon","year":"2015","journal-title":"J\u00a0Vet Emerg Crit Care (San Antonio)"},{"issue":"10","key":"10.1016\/j.cveq.2016.11.003_bib94","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S2213-8587(15)00224-7","article-title":"New insights into the controversy of adrenal function during critical illness","volume":"3","author":"Boonen","year":"2015","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["Veterinary Clinics of North America: Equine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749073916300785?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749073916300785?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T04:14:31Z","timestamp":1760069671000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749073916300785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":94,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S0749073916300785"],"URL":"https:\/\/doi.org\/10.1016\/j.cveq.2016.11.003","relation":{},"ISSN":["0749-0739"],"issn-type":[{"value":"0749-0739","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutics for Equine Endocrine Disorders","name":"articletitle","label":"Article Title"},{"value":"Veterinary Clinics of North America: Equine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cveq.2016.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}